Results 221 to 230 of about 312,815 (269)

Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2015
IMPORTANCE Supervised exercise is recommended as a first-line treatment for intermittent claudication. Combination therapy of endovascular revascularization plus supervised exercise may be more promising but few data comparing the 2 therapies are ...
F. Fakhry, S. Spronk, L. van der Laan, J. Wever, J. Teijink, W. H. Hoffmann, Taco M. Smits, J. V. van Brussel, G. Stultiens, A. Derom, P. den Hoed, G. Ho, Lukas C. van Dijk, N. Verhofstad, M. Orsini, A. V. van Petersen, Kristel Woltman, Ingrid Hulst, M. V. van Sambeek, D. Rizopoulos, E. Rouwet, M. G. Hunink   +21 more
semanticscholar   +1 more source

Pentoxifylline for intermittent claudication

2005
Intermittent claudication (IC) is a symptom of peripheral arterial occlusive disease (PAD). It is associated with high morbidity and mortality. Pentoxifylline is one of many drugs used to treat IC. Pentoxifylline decreases blood viscosity, improves erythrocyte flexibility, and increases microcirculatory flow and tissue oxygen concentration.Many studies
Kareem, Salhiyyah, Eshan, Senanayake, Mohammed, Abdel-Hadi, Andrew, Booth, Jonathan A, Michaels   +4 more
openaire   +2 more sources

Pharmacotherapy of intermittent claudication

Expert Opinion on Pharmacotherapy, 2001
Intermittent claudication (IC) is leg muscle pain, cramping and fatigue brought on by exercise and is the primary symptom of peripheral arterial disease. The goals of pharmacotherapy for IC are to increase the walking capacity/quality of life and to decrease rates of amputation.
openaire   +4 more sources

Prostanoids for intermittent claudication

2003
Peripheral arterial occlusive disease (PAOD) is a common cause of morbidity in the general population. While numerous studies have established the efficacy of prostanoids in PAOD stages III and IV the question of the role of prostanoids as an alternative or additive treatment in patients suffering from claudicatio intermittens (PAOD II) has not yet ...
Erich Minar, Robert A. Bucek, Markus Reiter, Andreas Stümpflen   +3 more
openaire   +3 more sources

Pseudo-Intermittent Claudication

Journal of Vascular Research, 1970
Intermittent claudication is caused by pain from an ischaemic muscle. Local tissue ischaemia is most often the result of an impairment of regional blood flow which is not a disease in itself but merely an event of a larger underlying disease which has to be searched for.
openaire   +3 more sources

Intermittent Claudication — Be Conservative

New England Journal of Medicine, 1991
Severe peripheral vascular disease is a common disorder that frequently creates substantial morbidity in our aging population.
openaire   +3 more sources

Pentoxifylline and Intermittent Claudication

Annals of Internal Medicine, 1985
Excerpt The Food and Drug Administration has recently approved the use of pentoxifylline, a methylxanthine with vasoactive properties (1), for the symptomatic treatment of intermittent claudication...
openaire   +3 more sources

Intermittent fasting in the prevention and treatment of cancer

Ca-A Cancer Journal for Clinicians, 2021
Katherine Clifton, Luigi Fontana, Lindsay L Peterson   +2 more
exaly  

Risk of major amputation in patients with intermittent claudication undergoing early revascularization

British Journal of Surgery, 2018
J. Golledge, J. Moxon, J. Moxon, Sophie E. Rowbotham, Sophie E. Rowbotham, Sophie E. Rowbotham, Jenna L. Pinchbeck, Lisan Yip, R. Velu, R. Velu, F. Quigley, Jason Jenkins, Dylan R. Morris, Dylan R. Morris   +13 more
semanticscholar   +1 more source

Cardiovascular and all‐cause mortality in patients with intermittent claudication and critical limb ischaemia

British Journal of Surgery, 2018
Steven T.W. van Haelst, C. Koopman, H. D. Ruijter, Frans L. Moll, F. Visseren, I. Vaartjes, G. J. Borst   +6 more
semanticscholar   +1 more source